Our group is strongly committed to explore and investigate tumor biology, particularly in those malignancies that rely on hormones for their development and progression.

​

Our  long-standing expertise in the field of hormone-related tumors like breast cancer has pushed us to focus our studies on the peculiar features that support this heterogeneous disease, in order to identify molecular, biochemical and biological vulnerabilities to be exploited in novel therapies.

​

We believe that our research efforts will strongly contribute to the identification of better pharmacological strategies that will improve precision medicine for oncological patients.